The activity of latent benzoperimidine esters to inhibit P-glycoprotein and multidrug resistance-associated protein 1 dependent efflux of pirarubicin from several lines of multidrug resistant tumor cells

Cancer Detection and Prevention
Dorota Głowacka-RogackaJolanta Tarasiuk

Abstract

Multidrug resistance of tumor cells is associated with the presence of membrane proteins responsible for the cytostatics export. Recently, we have synthesized a new family of benzoperimidines causing the futile cycle of MDR pumps. In this study, biological data for benzoperimidine esters are presented for selected cell lines: sensitive (HL-60, GLC4, K562), P-gp resistant (HL-60/VINC, K562/DX), MRP1 resistant (HL-60/DX) and MRP1/LRP resistant (GLC4/DX). Their ability to inhibit the efflux of anthracycline antitumor drug, pirarubicin and to restore its accumulation in MDR cells was studied using a spectrofluorometric method which allows to follow the uptake and efflux of fluorescent molecules by living cells. Benzoperimidine esters had high effectiveness in inhibiting pirarubicin efflux and in restoring its accumulation in resistant cells. In contrast, examined esters were less active in vitro in restoration of pirarubicin cytotoxicity towards resistant cells because an enzymatic cleavage of esters occurs in presence of serum esterases.

References

Oct 10, 1979·Nucleic Acids Research·A R MorganD H Evans
Mar 14, 1991·European Journal of Biochemistry·F Frezard, A Garnier-Suillerot
Jan 1, 1989·Canadian Journal of Physiology and Pharmacology·T R JonesP Masson
Sep 19, 1989·Biochimica Et Biophysica Acta·J TarasiukL Gattegno
Jan 1, 1986·Cancer Drug Delivery·T J LampidisH Tapiero
Feb 1, 1973·Analytical Biochemistry·G R Schacterle, R L Pollack
Jul 1, 1970·Journal of Medicinal Chemistry·W DaehneW O Godtfredsen
Mar 8, 1995·Biochemical and Biophysical Research Communications·V GekelerJ Beck
Jan 13, 1998·The Journal of Membrane Biology·F J Sharom
Dec 3, 1999·Biochimica Et Biophysica Acta·I KleinA Váradi
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·R Krishna, L D Mayer
Feb 28, 2001·European Journal of Pharmacology·K Tkaczyk-GobisA Garnier-Suillerot
Jan 24, 2002·Journal of Bioenergetics and Biomembranes·Z E SaunaS V Ambudkar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.